Home/ Stocks/ RVMD

Revolution Medicines, Inc. Common Stock

RVMD XNAS

$141.81 -0.70 (-0.49%) ▼ 15-min delayed

Open

$142.56

High

$144.61

Low

$140.53

Volume

2.51M

Market Cap

$30.15B

About Revolution Medicines, Inc. Common Stock

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 883 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-453,816,000	$-2.29
FY 2025	$0	$-1,131,301,000	$-5.95
Q3 2025	$0	$-305,206,000	$-1.61
Q2 2025	$0	$-247,787,000	$-1.31

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026

Calendar →

Related Market News

No specific coverage for RVMD yet. Check out our latest market news or earnings calendar.

Get RVMD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Revolution Medicines, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.